Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.1930
+0.0050 (2.66%)
Jun 3, 2026, 5:35 PM CET
EPA:ALVIO Market Cap
EPA:ALVIO has a market cap or net worth of €93.9 million as of June 3, 2026. Its market cap has increased by 838.20% in one year.
Market Cap
93.90M
Enterprise Value
101.16M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.19
Market Cap Chart
Since December 8, 2005, EPA:ALVIO's market cap has increased from 72.77M to 93.90M, an increase of 29.03%. That is a compound annual growth rate of 1.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 93.90M | 39.19% |
| Dec 31, 2025 | 67.46M | 484.18% |
| Dec 31, 2024 | 11.55M | -54.58% |
| Dec 29, 2023 | 25.42M | 62.58% |
| Dec 30, 2022 | 15.64M | -59.41% |
| Dec 31, 2021 | 38.52M | -25.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Transgene | 220.48M |
| Sensorion | 217.73M |
| Cellectis | 214.18M |
| Innate Pharma | 146.94M |
| ABIONYX Pharma | 98.82M |
| Adocia | 88.29M |
| OSE Immunotherapeutics | 85.69M |
| MaaT Pharma | 53.80M |